Ciclosporin 1mg/ml eye drops (Ikervis)
- BNF:
- Not listed
- Status:
- Grey - after consultant/specialist initiation
- Decision Date:
- March 2017
Comments
GREY after consultant/specialist initiation by secondary care or
specialist community optometry services (Decision date March 2025)
- NICE TA369 for the treatment of severe keratitis. Response to treatment should be reassessed at least every 6 months by the specialist.
Grey Drug Classifications
- 1: Lack of data on effectiveness compared with standard therapy
search again